Sernova (TSE:SVA) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Sernova Corp., a clinical-stage biotech firm, has announced an oversubscribed private placement of $4.7M, surpassing its $4M goal, with the final closing set for September 3, 2024. The company specializes in cell therapy technologies for chronic diseases with its flagship Cell Pouch System, aiming to create a ‘functional cure’ for insulin-dependent diabetes.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
